| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/10/2011 | CA2439170C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 05/10/2011 | CA2416293C Somatostatin analogues |
| 05/10/2011 | CA2304810C Tie receptor tyrosine kinase ligand homologues |
| 05/05/2011 | WO2011053901A2 Magnetic nanostructures as theranostic agents |
| 05/05/2011 | WO2011053618A2 Hydroxyl-terminated dendrimers |
| 05/05/2011 | WO2011052522A1 Diagnostic agent for infectious diseases |
| 05/05/2011 | WO2011052205A1 Polymer-coated ferrite microparticles and production method for same |
| 05/05/2011 | WO2011051422A2 Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents |
| 05/05/2011 | WO2011051387A1 Diagnostic composition comprising plasma cations having superior safety profile |
| 05/05/2011 | WO2011013038A3 Perfluoro compounds for use in imaging |
| 05/05/2011 | US20110107444 Novel poly(adp-ribose) polymerase genes |
| 05/05/2011 | US20110107442 Treatment of Male Sexual Dysfunction |
| 05/05/2011 | US20110107440 Skin cancer associated micrornas |
| 05/05/2011 | US20110107439 Diagnostic of pre-symptomatic metabolic syndrome |
| 05/05/2011 | US20110105825 Nanoparticle-sized magnetic absorption enhancers having three-dimensional geometries adapted for improved diagnostics and hyperthermic treatment |
| 05/05/2011 | US20110105380 Protection of Nano-Scale Particles from Immune Cell Uptake |
| 05/05/2011 | US20110104261 Remote detection of substance delivery to cells |
| 05/05/2011 | US20110104077 Magnetic nanocomposite with multi-biofunctional groups and method for fabricating the same |
| 05/05/2011 | US20110104075 129Xe BIOSENSORS AND THEIR USE |
| 05/05/2011 | US20110104074 Methods for targeted cancer treatment and detection |
| 05/05/2011 | US20110104073 Iron/Iron Oxide Nanoparticle and Use Thereof |
| 05/05/2011 | US20110104072 Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents |
| 05/05/2011 | US20110104071 Methods and systems for spatially identifying abnormal cells |
| 05/05/2011 | US20110104070 Site specific fluorescence and contrast marker for same |
| 05/05/2011 | US20110104069 Multi-functional biodegradable particles for selectable targeting, imaging, and therapeutic delivery and use thereof for treating ocular disorders |
| 05/05/2011 | US20110104068 Echogenic Coatings and Their Use in Medical Devices |
| 05/05/2011 | US20110104066 Prophylactic/therapeutic agents for lifestyle-related diseases |
| 05/05/2011 | US20110104065 Genetic alteration associated with pre-malignant cancer |
| 05/05/2011 | US20110104064 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals |
| 05/05/2011 | US20110104063 Flexibly labeling peptides |
| 05/05/2011 | US20110104062 Biomarkers for Head-And-Neck Cancers and Precancers |
| 05/05/2011 | US20110104061 Treatment of renal hypertension or carotid sinus syndrome with adventitial pharmaceutical sympathetic denervation or neuromodulation |
| 05/05/2011 | US20110104060 Treatment of hypertension by renal vascular delivery of guanethidine |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110104058 Dimeric molecular complexes |
| 05/05/2011 | US20110104057 Novel [F-18]-labelled L-glutamic acid and L-glutamine derivatives (II), their use and processes for their preparation |
| 05/05/2011 | US20110104056 Novel molecular assembly, molecular probe for molecular imaging and molecular probe for drug delivery system using the same, and molecular imaging system and drug delivery system |
| 05/05/2011 | US20110104053 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM |
| 05/05/2011 | US20110104052 Methods of synthesis and use of chemospheres |
| 05/05/2011 | US20110104051 Chemically Modified Viral Capsids as Targeted Delivery Vectors for Diagnostic and Therapeutic Agents |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | CA2779099A1 Templated nanoconjugates |
| 05/05/2011 | CA2777871A1 Treating water insoluble nanoparticles with hydrophilic alpha-hydroxyphosphonic acid conjugates, the so modified nanoparticles and their use as contrast agents |
| 05/05/2011 | CA2773685A1 Diagnostic composition comprising plasma cations having superior safety profile |
| 05/04/2011 | EP2316935A1 Aptamer against il-17 and use thereof |
| 05/04/2011 | EP2316493A2 Ethylenedicysteine (EC)-drug conjugates, compositions and methods for tissue specific disease imaging |
| 05/04/2011 | EP2316492A1 Para-hydrogen labelled magnetic resonance imaging contrast agent |
| 05/04/2011 | EP1465666B1 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy |
| 05/04/2011 | EP1414299B1 Method for making a homogenous doxorubicin -transferrin conjugate |
| 05/04/2011 | CN102043892A A molding and using method for a bulk drug gastrointestinal absorption prediction BSPK model |
| 05/04/2011 | CN102038964A Amorphous Fe-Co-B nano magnetic resonance contrast agent material and preparation method thereof |
| 05/04/2011 | CN102038963A Method for preparing a stabilised menthol emulsion |
| 05/04/2011 | CN102038962A Kit for detecting insulin allergen |
| 05/04/2011 | CN102038961A Method for establishing animal model for urothelium tumors of bladder in situ |
| 05/04/2011 | CN101596322B Aerial emulsion type ultraphonic contrast agent microballoon and preparation method thereof |
| 05/04/2011 | CN101475581B Terpyridyl complex two-photon material with cell development and preparation |
| 05/04/2011 | CN101155600B Radiotherapy enhancer |
| 05/04/2011 | CN101102799B Method of cardiac imaging with the use of hyperpolarized 13c-pyruvate |
| 05/03/2011 | US7935805 Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof |
| 05/03/2011 | US7935785 Selective substrates for matrix metalloproteinases |
| 05/03/2011 | US7935354 Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent state |
| 04/28/2011 | WO2011050052A2 Protein agent for diabetes treatment and beta cell imaging |
| 04/28/2011 | WO2011049961A2 Compositions and methods for imaging cells |
| 04/28/2011 | WO2011049256A1 Photosensitizer/metal nanoparticle charge complex and composition containing the complex for photodynamic therapy or diagnosis |
| 04/28/2011 | WO2011026824A3 Novel diagnostic agents for the non-invasive in vivo imaging of aminopeptidase n (apn/cd13) |
| 04/28/2011 | WO2011021001A8 Peptidic conjugates comprising polyhistidine sequence and free cysteine and their uses in imaging |
| 04/28/2011 | WO2011014721A3 Genetically modified rat models for pharmacokinetics |
| 04/28/2011 | US20110099647 Antibodies against cd38 for treatment of multiple myeloma |
| 04/28/2011 | US20110098578 Optical imaging of rheumatoid arthritis |
| 04/28/2011 | US20110098353 Compounds for Imaging and Therapy |
| 04/28/2011 | US20110097330 Novel Gene Disruptions, Compostitions and Methods Relating Thereto |
| 04/28/2011 | US20110097280 Intracorporeal Medicaments for Photodynamic Treatment of Disease |
| 04/28/2011 | US20110097277 Particles coated with zwitterionic polymers |
| 04/28/2011 | US20110097276 Diagnosis of Prostate Cancer |
| 04/28/2011 | US20110097275 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
| 04/28/2011 | US20110097274 Carbon-11 and fluorine-18 labeled radioligands for positron emission tomography (PET) imaging for the brain serotonin transporters |
| 04/28/2011 | US20110097273 Spectral imaging |
| 04/28/2011 | US20110097272 Method and Materials for Use in Diagnosing Viral Myocarditis |
| 04/28/2011 | US20110097271 Colon Cancer Associated Transcript 1 (CCAT1) As A Cancer Marker |
| 04/28/2011 | US20110097270 Monoclonal Antibodies That Bind or Neutralize Hepatitis B Virus |
| 04/28/2011 | US20110097269 Phenyloxyaniline derivatives |
| 04/28/2011 | US20110097267 Compositions for imaging pain and stress in vivo |
| 04/28/2011 | US20110097265 Quantification method for remaining liver function and novel liver receptor imaging agent |
| 04/28/2011 | US20110097261 Amigo-2-inhibitors for treating, diagnosing or detecting cancer |
| 04/28/2011 | CA2778533A1 Peptides that bind the alpha-fetoprotein (afp) receptor and uses thereof |
| 04/27/2011 | CN102036713A Methods relating to breathing disorders |
| 04/27/2011 | CN102036684A RGD-(bacterio)chlorophyll conjugates for photodynamic therapy and imaging of necrotic tumors |
| 04/27/2011 | CN102028961A Ultrasonic coupling agent used by traumatic patient after surgery |
| 04/27/2011 | CN102028960A New application of normal saline injection |
| 04/27/2011 | CN102028959A Tumor targeting paramagnetic liposome for magnetic resonance diagnosis and preparation method thereof |
| 04/27/2011 | CN101569751B Tumor-targeted nonionic dendritic macromolecule magnetic resonance imaging contrast agent |
| 04/26/2011 | US7932356 Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition |
| 04/26/2011 | US7932049 Methods of identifying longevity modulators and therapeutic methods of use thereof |
| 04/26/2011 | CA2496611C Agent delivery particle |
| 04/26/2011 | CA2428785C Nanoparticulate compositions comprising a drug and copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers |
| 04/26/2011 | CA2201482C Novel ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/21/2011 | WO2011047277A2 Release of agents from cells |
| 04/21/2011 | WO2011046437A1 Composition and method for medical imaging of body cavities |
| 04/21/2011 | WO2011044671A1 Porphyrin nanovesicles |
| 04/21/2011 | WO2011005322A3 N-alkoxyamide conjugates as imaging agents |